5432-0 |
CD126 |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD126 cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5432-0 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD126 WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; CELL MARKERS; IL-6R; Interleukin-6 receptor; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54320-7 |
Octanoylcarnitine (C8)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Octanoylcarnitine (C8)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54320-7 |
|
|
|
|
Both |
|
|
|
0 |
Octanoylcarn/Creat Ur-sRto |
|
|
|
N |
|
C8; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54321-5 |
Octanoylcarnitine (C8) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Octanoylcarnitine (C8) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54321-5 |
|
|
|
|
Both |
|
|
|
0 |
Octanoylcarn CSF-sCnc |
|
|
|
N |
|
C8; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54322-3 |
Octanoylcarnitine (C8) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Octanoylcarnitine (C8) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54322-3 |
|
|
|
|
Both |
|
|
|
0 |
Octanoylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C8; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54323-1 |
Palmitoylcarnitine (C16)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Palmitoylcarnitine (C16)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54323-1 |
|
|
|
|
Observation |
|
|
|
0 |
Palmitoylcarn/Creat Ur-sRto |
|
|
|
N |
|
C16; Chemistry; CR; Crea; Creat; Hexadecanoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54324-9 |
Palmitoylcarnitine (C16) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Palmitoylcarnitine (C16) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54324-9 |
|
|
|
|
Both |
|
|
|
0 |
Palmitoylcarn CSF-sCnc |
|
|
|
N |
|
C16; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hexadecanoylcarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54325-6 |
Palmitoylcarnitine (C16) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Palmitoylcarnitine (C16) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54325-6 |
|
|
|
|
Both |
|
|
|
0 |
Palmitoylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C16; Chemistry; Hexadecanoylcarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54326-4 |
Phosphoethanolamine |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Phosphoethanolamine [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54326-4 |
|
|
|
|
Both |
|
|
|
0 |
PETN DBS-sCnc |
|
|
|
N |
|
Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; PEA; PETN; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54327-2 |
Pipecolate |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Pipecolate [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54327-2 |
|
|
|
|
Both |
|
|
|
0 |
Pipecolate CSF-sCnc |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Pipa; Pipecolic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54328-0 |
Pipecolate |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Pipecolate [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54328-0 |
|
|
|
|
Both |
|
|
|
0 |
Pipecolate DBS-sCnc |
|
|
|
N |
|
Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Pipa; Pipecolic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54329-8 |
Propionylcarnitine (C3)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Propionylcarnitine (C3)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54329-8 |
|
|
|
|
Both |
|
|
|
0 |
Propionylcarn/Creat Ur-sRto |
|
|
|
N |
|
C3; C3-carntitine; Chemistry; CR; Crea; Creat; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
5433-8 |
CD128 |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD128 cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5433-8 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD128 WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; CELL MARKERS; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54330-6 |
Propionylcarnitine (C3) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Propionylcarnitine (C3) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54330-6 |
|
|
|
|
Both |
|
|
|
0 |
Propionylcarn CSF-sCnc |
|
|
|
N |
|
C3; C3-carntitine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54331-4 |
Propionylcarnitine (C3) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Propionylcarnitine (C3) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54331-4 |
|
|
|
|
Both |
|
|
|
0 |
Propionylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C3; C3-carntitine; Chemistry; Level; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54332-2 |
Propionylglycine |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Propionylglycine [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54332-2 |
|
|
|
|
Both |
|
|
|
0 |
Propionylgly CSF-sCnc |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54333-0 |
Stearoylcarnitine (C18)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Stearoylcarnitine (C18)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54333-0 |
|
|
|
|
Both |
|
|
|
0 |
Stearoylcarn/Creat Ur-sRto |
|
|
|
N |
|
C18; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Steroylcarnitine; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54334-8 |
Stearoylcarnitine (C18) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Stearoylcarnitine (C18) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54334-8 |
|
|
|
|
Both |
|
|
|
0 |
Stearoylcarn CSF-sCnc |
|
|
|
N |
|
C18; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Steroylcarnitine; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54335-5 |
Stearoylcarnitine (C18) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Stearoylcarnitine (C18) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54335-5 |
|
|
|
|
Both |
|
|
|
0 |
Stearoylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C18; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Steroylcarnitine; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54336-3 |
Sulfocysteine |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Sulfocysteine [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54336-3 |
|
|
|
|
Both |
|
|
|
0 |
Sulfocysteine CSF-sCnc |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Cys(SO3H); Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54337-1 |
Sulfocysteine |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Sulfocysteine [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54337-1 |
|
|
|
|
Both |
|
|
|
0 |
Sulfocysteine DBS-sCnc |
|
|
|
N |
|
Blood; Chemistry; Cys(SO3H); DBS; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54338-9 |
Tetradecanoylcarnitine (C14)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Tetradecanoylcarnitine (C14)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54338-9 |
|
|
|
|
Both |
|
|
|
0 |
Tdecanoylcarn/Creat Ur-sRto |
|
|
|
N |
|
C14; Chemistry; CR; Crea; Creat; Myristoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Tdecanoylcarn; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54339-7 |
Tetradecanoylcarnitine (C14) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Tetradecanoylcarnitine (C14) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54339-7 |
|
|
|
|
Both |
|
|
|
0 |
Tdecanoylcarn CSF-sCnc |
|
|
|
N |
|
C14; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Myristoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Tdecanoylcarn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
5434-6 |
CD13 |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD13 cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5434-6 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD13 WBC-aCnc |
|
|
|
|
|
Aminopeptidase n; APN; Arbitrary concentration; CELL MARKERS; gp150; Leukocytes; LeuM7; Leu-M7; My7; My-7; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54340-5 |
Tetradecanoylcarnitine (C14) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Tetradecanoylcarnitine (C14) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54340-5 |
|
|
|
|
Both |
|
|
|
0 |
Tdecanoylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C14; Chemistry; Level; Myristoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tdecanoylcarn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54341-3 |
Myristoleate/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Myristoleate (C14:1)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54341-3 |
|
|
|
|
Both |
|
|
|
0 |
Myristoleate/Creat Ur-sRto |
|
|
|
N |
|
C14:1; Chemistry; cis-9-tetradecenoate; cis-9-tetradecenoic acid; CR; Crea; Creat; Myristoleic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |